Detalhe da pesquisa
1.
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A.
Nature
; 603(7899): 124-130, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197626
2.
Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases.
Brain
; 147(4): 1483-1496, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37831661
3.
Synthesizing images of tau pathology from cross-modal neuroimaging using deep learning.
Brain
; 147(3): 980-995, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804318
4.
Altered structural and functional connectivity in Posterior Cortical Atrophy and Dementia with Lewy bodies.
Neuroimage
; 290: 120564, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442778
5.
Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion.
Acta Neuropathol
; 147(1): 73, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641715
6.
Role of GBA variants in Lewy body disease neuropathology.
Acta Neuropathol
; 147(1): 54, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472443
7.
Clinicoradiological and neuropathological evaluation of primary progressive aphasia.
J Neurol Neurosurg Psychiatry
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514176
8.
Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test.
J Int Neuropsychol Soc
; 30(2): 138-151, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385974
9.
Mayo normative studies: regression-based normative data for ages 30-91 years with a focus on the Boston Naming Test, Trail Making Test and Category Fluency.
J Int Neuropsychol Soc
; 30(4): 389-401, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014536
10.
Determinants of confrontation naming deficits on the Boston Naming Test associated with transactive response DNA-binding protein 43 pathology.
J Int Neuropsychol Soc
; : 1-9, 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38525671
11.
Predicting amyloid PET and tau PET stages with plasma biomarkers.
Brain
; 146(5): 2029-2044, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789483
12.
Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis.
Brain
; 146(11): 4508-4519, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279785
13.
Case report: pre-symptomatic clinical and metabolic profile in posterior cortical atrophy and dementia with Lewy bodies.
Neurocase
; 30(1): 1-7, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758704
14.
FedFSA: Hybrid and federated framework for functional status ascertainment across institutions.
J Biomed Inform
; 152: 104623, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458578
15.
Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer's disease.
Cereb Cortex
; 33(11): 7026-7043, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721911
16.
Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment, Alzheimer's disease, Alzheimer's disease-related dementias, and other cognitive disorders: a systematic review and meta-analysis.
Int Psychogeriatr
; : 1-49, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38329083
17.
Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET.
Alzheimers Dement
; 20(2): 1225-1238, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963289
18.
Vascular risk, gait, behavioral, and plasma indicators of VCID.
Alzheimers Dement
; 20(2): 1201-1213, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932910
19.
Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals.
Alzheimers Dement
; 20(3): 2143-2154, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265198
20.
Significance of a positive tau PET scan with a negative amyloid PET scan.
Alzheimers Dement
; 20(3): 1923-1932, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159060